Jaffer Alsolaiss

650 total citations
16 papers, 440 citations indexed

About

Jaffer Alsolaiss is a scholar working on Genetics, Virology and Paleontology. According to data from OpenAlex, Jaffer Alsolaiss has authored 16 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Virology and 4 papers in Paleontology. Recurrent topics in Jaffer Alsolaiss's work include Venomous Animal Envenomation and Studies (16 papers), Rabies epidemiology and control (15 papers) and Marine Invertebrate Physiology and Ecology (4 papers). Jaffer Alsolaiss is often cited by papers focused on Venomous Animal Envenomation and Studies (16 papers), Rabies epidemiology and control (15 papers) and Marine Invertebrate Physiology and Ecology (4 papers). Jaffer Alsolaiss collaborates with scholars based in United Kingdom, Netherlands and Malaysia. Jaffer Alsolaiss's co-authors include Nicholas R. Casewell, Robert A. Harrison, Stuart Ainsworth, Laura-Oana Albulescu, Edouard Crittenden, Jeroen Kool, Chunfang Xie, Paul Rowley, Hastings Ozwara and José Marı́a Gutiérrez and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jaffer Alsolaiss

16 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaffer Alsolaiss United Kingdom 11 400 295 172 135 34 16 440
Stephen P. Samuel United States 8 413 1.0× 269 0.9× 186 1.1× 143 1.1× 40 1.2× 13 442
Ana Silvia Arias Costa Rica 9 368 0.9× 257 0.9× 182 1.1× 96 0.7× 32 0.9× 9 398
Daniela Solano Costa Rica 7 301 0.8× 204 0.7× 123 0.7× 109 0.8× 32 0.9× 12 311
Mátyás A. Bittenbinder Netherlands 9 279 0.7× 156 0.5× 127 0.7× 110 0.8× 25 0.7× 19 307
Diana Mora-Obando Costa Rica 11 429 1.1× 251 0.9× 192 1.1× 159 1.2× 37 1.1× 17 459
Christeine Ariaranee Gnanathasan Sri Lanka 15 497 1.2× 351 1.2× 123 0.7× 218 1.6× 52 1.5× 20 531
Kin Ying Wong Malaysia 11 450 1.1× 275 0.9× 190 1.1× 219 1.6× 48 1.4× 13 455
Edouard Crittenden United Kingdom 10 281 0.7× 211 0.7× 122 0.7× 93 0.7× 24 0.7× 17 311
Fiona Bolton United Kingdom 7 451 1.1× 295 1.0× 162 0.9× 134 1.0× 39 1.1× 8 475
Silvana Maruñak Argentina 12 359 0.9× 218 0.7× 143 0.8× 102 0.8× 65 1.9× 33 381

Countries citing papers authored by Jaffer Alsolaiss

Since Specialization
Citations

This map shows the geographic impact of Jaffer Alsolaiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaffer Alsolaiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaffer Alsolaiss more than expected).

Fields of papers citing papers by Jaffer Alsolaiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaffer Alsolaiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaffer Alsolaiss. The network helps show where Jaffer Alsolaiss may publish in the future.

Co-authorship network of co-authors of Jaffer Alsolaiss

This figure shows the co-authorship network connecting the top 25 collaborators of Jaffer Alsolaiss. A scholar is included among the top collaborators of Jaffer Alsolaiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaffer Alsolaiss. Jaffer Alsolaiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Alsolaiss, Jaffer, et al.. (2024). Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model. Toxins. 16(6). 276–276. 3 indexed citations
2.
Menzies, Stefanie K., Rachel H. Clare, Chunfang Xie, et al.. (2022). In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. SHILAP Revista de lepidopterología. 14. 100118–100118. 23 indexed citations
3.
Menzies, Stefanie K., Edouard Crittenden, Steven R. Hall, et al.. (2022). Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition. Scientific Reports. 12(1). 11328–11328. 6 indexed citations
4.
Menzies, Stefanie K., Jaffer Alsolaiss, Edouard Crittenden, et al.. (2022). Two snakebite antivenoms have potential to reduce Eswatini’s dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing. PLoS neglected tropical diseases. 16(9). e0010496–e0010496. 10 indexed citations
5.
Blundell, Patricia A., Jaffer Alsolaiss, Edouard Crittenden, et al.. (2022). Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms. Toxins. 14(7). 443–443. 13 indexed citations
6.
Chinnappan, Raja, et al.. (2022). Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming. Toxins. 14(7). 469–469. 15 indexed citations
9.
Albulescu, Laura-Oana, Chunfang Xie, Stuart Ainsworth, et al.. (2021). Author Correction: A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. Nature Communications. 12(1). 4027–4027. 2 indexed citations
10.
Alsolaiss, Jaffer, Laura-Oana Albulescu, Edouard Crittenden, et al.. (2021). Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms. PLoS neglected tropical diseases. 15(8). e0009659–e0009659. 12 indexed citations
11.
Albulescu, Laura-Oana, Chunfang Xie, Stuart Ainsworth, et al.. (2020). A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite. Nature Communications. 11(1). 6094–6094. 112 indexed citations
12.
Chaisakul, Janeyuth, Jaffer Alsolaiss, Laura-Oana Albulescu, et al.. (2020). In Vitro Immunological Cross-Reactivity of Thai Polyvalent and Monovalent Antivenoms with Asian Viper Venoms. Toxins. 12(12). 766–766. 15 indexed citations
13.
Albulescu, Laura-Oana, Stuart Ainsworth, Jaffer Alsolaiss, et al.. (2020). Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite. Science Translational Medicine. 12(542). 68 indexed citations
14.
Chaisakul, Janeyuth, Jaffer Alsolaiss, Robert A. Harrison, et al.. (2019). Evaluation of the geographical utility of Eastern Russell’s viper (Daboia siamensis) antivenom from Thailand and an assessment of its protective effects against venom-induced nephrotoxicity. PLoS neglected tropical diseases. 13(10). e0007338–e0007338. 25 indexed citations
15.
Albulescu, Laura-Oana, Taline D. Kazandjian, Julien Slagboom, et al.. (2019). A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite. Frontiers in Pharmacology. 10. 848–848. 34 indexed citations
16.
Harrison, Robert A., Stuart Ainsworth, Jaffer Alsolaiss, et al.. (2017). Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS neglected tropical diseases. 11(10). e0005969–e0005969. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026